Royalty Pharma plc (RPRX)

NASDAQ: RPRX · Real-Time Price · USD

67.18

+1.25 (1.90%)

At close: Oct 30, 2026, 4:00 PM EDT

67.25

+0.07 (0.10%)

After-hours: Oct 30, 2026, 7:32 PM EDT

Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	38,629	16,509	11,334	12,497	17,432	17,116
Market Cap Growth	143.68%	45.66%	-9.30%	-28.31%	1.85%	-11.89%
Enterprise Value	46,753	27,726	21,332	21,132	27,333	26,687
Last Close Price	67.18	38.12	24.55	26.21	35.95	35.60

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	36.03	21.41	13.20	11.01	407.00	27.62
Forward PE	12.19	7.70	6.10	7.47	10.32	13.00
PS Ratio	15.23	6.94	5.01	5.31	7.79	7.48
PB Ratio	4.38	1.70	1.10	1.24	1.83	1.67
P/TBV Ratio	6.54	2.97	1.63	1.92	3.11	2.97
P/OCF Ratio	12.98	6.63	4.09	4.18	8.13	8.48
PEG Ratio	1.64	0.79	2.14	2.65	0.94	1.12

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	18.44	11.66	9.42	8.98	12.22	11.66
EV/EBITDA Ratio	30.02	17.74	-	14.11	29.44	18.36
EV/EBIT Ratio	30.12	17.78	16.51	14.16	29.62	18.65

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.92	0.92	0.74	0.61	0.75	0.69
Debt / EBITDA Ratio	5.75	5.74	-	4.10	7.66	4.88
Net Debt / Equity Ratio	0.83	0.86	0.64	0.56	0.56	0.48
Net Debt / EBITDA Ratio	5.22	5.33	-	3.77	5.79	3.38
Asset Turnover	0.13	0.13	0.13	0.14	0.13	0.14
Quick Ratio	2.79	2.39	1.43	7.78	2.11	16.77
Current Ratio	2.80	2.40	1.44	7.90	2.19	16.81
Return on Equity (ROE)	13.96%	13.20%	13.03%	17.34%	2.33%	12.32%
Return on Assets (ROA)	5.09%	5.15%	4.67%	5.62%	3.36%	5.33%
Return on Capital Employed (ROCE)	8.10%	8.20%	7.60%	9.20%	5.90%	8.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.78%	4.67%	7.58%	9.08%	0.25%	3.62%
Dividend Yield	1.40%	2.28%	3.31%	2.86%	1.93%	1.72%
Payout Ratio	50.42%	49.06%	43.83%	31.57%	778.21%	46.02%
Buyback Yield / Dilution	3.88%	4.99%	1.46%	-37.66%	-5.59%	-10.48%
Total Shareholder Return	5.28%	7.28%	4.76%	-34.80%	-3.65%	-8.76%

SEC Filings: 10-K · 10-Q